Biote (BTMD) Net Income towards Common Stockholders (2021 - 2026)

Biote's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 83.4% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $15.6 million (down 25.82% YoY), while the FY2025 annual figure was $27.0 million, up 756.67% from the prior year.
• Net Income towards Common Stockholders was $2.3 million for Q1 2026 at Biote, up from $2.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $13.7 million in Q1 2025 to a low of -$21.3 million in Q2 2022.
• Historically, Net Income towards Common Stockholders has averaged $2.3 million across 5 years, with a median of $3.2 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders plunged 318.51% in 2022, then soared 50100.0% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at $9.8 million in 2022, then increased by 26.72% to $12.5 million in 2023, then slumped by 70.31% to $3.7 million in 2024, then plunged by 47.23% to $2.0 million in 2025, then grew by 16.53% to $2.3 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $2.3 million (Q1 2026), $2.0 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.